PFE
Pfizer Inc.“P/E well below pharma industry average of 16.2; positive EPS growth of 12% YoY from pipeline drugs; low debt-to-equity of 0.35; analysts project 38% upside to $42 target.”
- Rank
- 1
- P/E
- 8.7
From morning briefings to real-time alerts, Capital Sound transforms how you consume financial intelligence.
Start your day with AI-curated audio summaries of global markets, earnings, and trends.

Track your portfolio with real-time prices and one-tap audio briefings for any stock.

Get executive summaries, technical analysis, and actionable recommendations instantly.

Follow along with synchronized transcripts while listening to financial news.

Access exclusive TOP 10 picks based on insider trading signals and sentiment gaps.

Essential market updates.
For the serious investor.
Professional grade intelligence.
Ultimate financial mastery.
All plans include access to the Capital Sound iOS app. Cancel anytime.
“CapitalSound changed how I commute. I get my entire market briefing before I even park my car. The voice quality is insane.”
“The personalized earnings alerts are a game changer. I knew about the NVDA dip before my team did.”
“Finally, an app that respects my time. No fluff, just the financial intelligence I need.”
“It’s like having a Bloomberg terminal in your pocket, but it talks to you. Highly recommended.”
“The audio quality is crystal clear, and the summarization is spot on. I use it every morning.”
“Love the crypto updates alongside traditional stocks. Keeps me in the loop on everything.”
Everything you need to know about Capital Sound.
Capital Sound is an audio-first financial intelligence app for iOS. It transforms how you consume market news by delivering AI-curated daily briefings, stock insights, and earnings analysis directly to your ears. Think of it as your personal financial podcast that updates in real-time.
Each morning our AI runs eight separate analytical screens — undervalued names, insider buying, dividend aristocrats, sector rotations, and four more. The full set lives in the iOS app. Today’s undervalued screen is below.
“P/E well below pharma industry average of 16.2; positive EPS growth of 12% YoY from pipeline drugs; low debt-to-equity of 0.35; analysts project 38% upside to $42 target.”
P/E below semiconductor avg of 22.8; 8% earnings growth expected from foundry expansion; debt-to-equity 0.28; 42% upside to $48 consensus.
P/E under networking peers at 19.5; steady 6% earnings growth; debt-to-equity 0.22; 35% upside to $62 target price.
Tomorrow’s screen lands at 6 AM ET. Get it via push in the iOS app.
Earnings, central-bank decisions, the data prints that move markets — all the dates worth watching, in one row.
Looking further than this week? The full 90-day calendar lives in the iOS app, with native iOS Calendar sync.